IF: 0.587
Cite Score:
0.7
THOMSON REUTERS - SCOPUS

Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran

AUTHORS

Gholamhossein Ajami 1 , Khashayar Aflaki 2 , Behrooz Gharesi-fard 3 , Mohammad Borzouee 4 , Hamid Amoozgar 5 , *

AUTHORS INFORMATION

1

2

3

4

5

How to Cite: Ajami G , Aflaki K , Gharesi-fard B , Borzouee M , Amoozgar H . Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran, Iran J Pediatr. 2014 ; 24(4):359-364.

ARTICLE INFORMATION

Iranian Journal of Pediatrics: 24 (4); 359-364
Published Online: May 24, 2014
Article Type: Research Article
Received: October 07, 2013
Accepted: May 14, 2014

Crossmark

CHEKING

READ FULL TEXT
Abstract

Objective: Kawasaki disease (KD) clinically presents as a systemic vasculitis syndrome with significant cardiovascular involvement. With different incidence among different ethnic groups, the role of certain human leukocyte antigens and their products has been considered as a crucial predisposing factor in the immune responses in this disease.Methods: We determined the distribution of human leukocyte antigens type B for 90 Iranian patients with Kawasaki disease in order to evaluate a possible association between these antigens and this disease in our area. We used the polymerase chain reaction (PCR) sequence specific primers (PCR-SSP) technique for antigen typing. Distribution of these antigens for 89 healthy Iranians used as control.Findings: While 7 (3.9%) of our patients were positive for human leukocyte antigen type B 40*, there were 18 (10.1%) subjects from the control group who had this antigen with statistically significant difference between patients and control group (CI= 95%, RR=1.15 and P= 0.02). Data were analyzed by Pearson chi-square test and Fisher's exact test. SPSS version 15 was used for statistical analysis and a P value less than 0.05 considered statistically significantConclusion: The presence of higher frequency of allele type-B40* in the control group may represent a protective role for this antigen with resultant decreased susceptibility to KD in our area.

 

Keywords

Kawasaki Disease Gene Protection Human Leukocyte Antigens HLA- B40* Allele

© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

References

  • 1. References are available on the PDF.
  • COMMENTS

    LEAVE A COMMENT HERE: